Drugs for Aspiration Pneumonitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 190)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Sodium citrate |
Approved, Investigational |
Phase 4 |
|
68-04-2 |
|
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
|
Sodium citrate, anhydrous
Sodium citrate,anhydrous
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
2 |
|
Magnesium oxide |
Approved |
Phase 4 |
|
1309-48-4 |
14792 |
Synonyms:
|
3 |
|
Magnesium citrate |
Approved |
Phase 4 |
|
3344-18-1 |
|
Synonyms:
Magnesium dicitrate
Trimagnesium citrate
|
|
|
4 |
|
Fentanyl |
Approved, Illicit, Investigational, Vet_approved |
Phase 4 |
|
437-38-7 |
3345 |
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-phenethyl-4-N-propionylanilinopiperidine
1-Phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Actiq
BIDD:GT0555
BRN 0494484
Cephalon brand OF fentanyl buccal oravescent
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
fentanyl
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl [INN:BAN]
Fentanyl CII
Fentanyl citrate
Fentanyl-100
Fentanyl-12
Fentanyl-25
Fentanyl-50
|
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
Fentora
HSDB 3329
IONSYS
Janssen pharmaceutica brand OF fentanyl
JNS020QD
L001275
LS-124439
Matrifen
MolPort-003-847-369
N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
Nasalfent
NCGC00168252-01
N-phenethyl-4-(N-propionylanilino)piperidine
N-Phenethyl-4-(N-propionylanilino)piperidine
N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
Transmucosal oral fentanyl citrate
UNII-UF599785JZ
|
|
5 |
|
Clavulanate |
Approved, Vet_approved |
Phase 4 |
|
58001-44-8 |
5280980 |
Synonyms:
(2R,3Z,5R)-3-(2-HYDROXYETHYLIDENE)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2R,3Z,5R)-3-(2-HYDROXYETHYLIDENE)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylIC ACID
(Z)-(2R,5R)-3-(2-Hydroxyethyliden)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptan-2-carbonsaeure
(Z)-(2R,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylate
(Z)-(2R,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
3008-B
4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, (2R-(2alpha,3Z,5alpha))
57943-81-4 (mono-hydrochloride-salt)
58001-44-8
61177-45-5 (mono-potassium-salt)
AC1NQXUM
Acide clavulanique
Acide clavulanique [INN-French]
acido Clavulanico
Acido clavulanico
ácido clavulánico
Acido clavulanico [INN-Spanish]
acidum clavulanicum
Acidum clavulanicum
Acidum clavulanicum [INN-Latin]
Antibiotic MM 14151
BRL-14151
BRN 0787059
BSPBio_002430
C06662
C8H9NO5
CHEBI:48947
CHEMBL777
CID5280980
Clavulanate
|
Clavulanate potassium
Clavulanate, potassium
Clavulanate, sodium
Clavulanic acid
Clavulanic Acid
CLAVULANIC ACID
Clavulanic acid (INN)
Clavulanic acid [BAN:INN]
Clavulanic acid, monopotassium salt
Clavulanic acid, monosodium salt
Clavulansaeure
Clavulansaeure [INN]
Clavulansäure
Clavulinic Acid
Clavulonate
Clavulonic acid
Clavulox
Clavulox (TN)
D07711
DB00766
EINECS 261-069-2
J01
LS-98544
MM 14151
MM-14151
Potassium clavulanate
Potassium, clavulanate
Sodium clavulanate
Sodium Clavulanate
UNII-23521W1S24
|
|
6 |
|
Amoxicillin |
Approved, Vet_approved |
Phase 4 |
|
26787-78-0 |
33613 |
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(a-amino-4-hydroxyphenylacetamido)Penicillanic acid
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(D-(-)-P-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-a-aminophenylacetamido)penicillanate
6-(P-Hydroxy-a-aminophenylacetamido)penicillanic acid
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanate
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(P-Hydroxy-α-aminophenylacetamido)penicillanate
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-(P-Hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[amino(4-Hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9ci
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
a-amino-P-Hydroxybenzylpenicillin
AC-12263
AC1L1PY2
Actimoxi
Almodan
alpha-amino-P-Hydroxybenzylpenicillin
alpha-Amino-p-hydroxybenzylpenicillin
Ambap26787-78-0
AMC
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 cap 250MG
Amox 500 cap 500MG
Amox S 125 sus 125mg/5ML
Amox S 250 sus 250mg/5ML
Amoxi
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
amoxicillanyl
amoxicillin
Amoxicillin
Amoxicillin (anhydrous)
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin clariana brand
AMOXICILLIN CRYSTALLINE
Amoxicillin monopotassium salt
Amoxicillin monosodium salt
Amoxicillin pediatric
AMOXICILLIN PEDIATRIC
Amoxicillin sodium
Amoxicillin trihydrate
Amoxicillin Trihydrate
Amoxicillin(usan)
Amoxicillin, (r*)-isomer
Amoxicilline
Amoxicilline [INN]
Amoxicilline [INN-French]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxi-mast
Amoxi-Mast
Amoxivet
Amoxycilin
Amoxycillin
Amoxycillin trihydrate
Amoxycillin Trihydrate
Amoxycillin, ban
Amoxymed
AMPC
Amrit
Anemolin
Anhydrous, amoxicillin
apo-Amoxi
Apo-Amoxi
apo-Amoxi cap 250MG
apo-Amoxi cap 500MG
apo-Amoxi PWR for susp 125mg/5ML
apo-Amoxi PWR for susp 250mg/5ML
apo-Amoxi sugar free
Aspenil
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN es-600
AX
Biomox
BLP 1410
BL-P 1410
|
BPBio1_000499
BRD-K55044200-001-03-9
Bristamox
BRL 2333
BRL-2333
BSPBio_000453
C06827
Cemoxin
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
Clamoxyl
Clamoxyl (SKB)
Clamoxyl g.a.
Clamoxyl parenteral
Clariana brand OF amoxicillin
CPD000058707
D-(-)-alpha-amino-P-Hydroxybenzyl penicillin
D-(-)-alpha-amino-P-Hydroxybenzylpenicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-amino-P-Hydroxybenzyl)penicillin
D07452
D-2-amino-2-(4-Hydroxyphenyl)acetamidopenicillanic acid
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
DB01060
Delacillin
Dispermox
DisperMox
Efpenix
EINECS 248-003-8
Flemoxin
G.A., clamoxyl
Galenamox
Gen-amoxicillin 250MG
Gen-amoxicillin 500MG
Hiconcil
Histocillin
HMS1569G15
HSDB 3204
Hydroxyampicillin
Ibiamox
Imacillin
Lamoxy
Larotid
LS-149721
Metafarma capsules
Metifarma capsules
MLS000028632
MLS002222248
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
Novamoxin cap 250MG
Novamoxin cap 500MG
Novamoxin sus 125mg/5ML
Novamoxin sus 250mg/5ML
NSC 277174
NSC277174
Nu-amoxi cap 250MG
Nu-amoxi cap 500MG
Nu-amoxi sus 125/5ML
Nu-amoxi sus 250mg/5ML
Ospamox
Pamoxicillin
Parenteral, clamoxyl
Penamox
Pfizer brand OF amoxicillin sodium salt
PHL-Amoxicillin
p-Hydroxyampicillin
P-Hydroxyampicillin
Piramox
PMS-Amoxicillin
Polymox
Prestwick_713
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prevpac
pro Amox PWR for oral susp 125mg/5ML
pro Amox-250 cap 250MG
pro Amox-500 cap 500MG
pro-Amox-250 orl sus 250mg/5ML
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
Sauracillin
Sawamox PM
SmithKline beecham brand OF amoxicillin sodium salt
SMR000058707
Sodium, amoxicillin
SPBio_002374
Sumox
Tolodina
Trihydrate, amoxicillin
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
α-amino-p-hydroxybenzylpenicillin
α-amino-P-hydroxybenzylpenicillin
|
|
7 |
|
Propofol |
Approved, Investigational, Vet_approved |
Phase 4 |
|
2078-54-8 |
4943 |
Synonyms:
2, 6-Diisopropylphenol
2,6 Diisopropylphenol
2,6-bis(1-methylethyl)phenol
2,6-bis(1-methylethyl)-phenol
2,6-Bis(1-methylethyl)phenol
2,6-Bis(Isopropyl)-phenol
2,6-di(propan-2-yl)phenol
2,6-Diisopropyl phenol
2,6-Diisopropylphenol
2,6-DIISOPROPYLPHENOL
2078-54-8
28449-97-0
4-06-00-03435 (Beilstein Handbook Reference)
50356-15-5
AB00513968
Abbott brand OF propofol
Abbott Brand of Propofol
AC1L1J9Y
AC1Q1OUI
AC-2038
AI3-26295
Alpha Brand of Propofol
Alpha Brand OF propofol
AM-149
Ampofol
Aquafol
Astra brand OF propofol
Astra Brand of Propofol
AstraZeneca brand OF propofol
AstraZeneca Brand of Propofol
BIDD:GT0436
Biomol-NT_000248
BPBio1_000950
BPBio1_000969
Braun brand OF propofol
Braun Brand of Propofol
BRD-K82255054-001-03-5
BRN 1866484
BSPBio_000862
C07523
C12H18O
CAS-2078-54-8
CCRIS 9000
CHEBI:44915
CHEMBL526
CID4943
CPD000059151
CPD-11437
Curamed brand OF propofol
Curamed Brand of Propofol
D00549
D015742
D0617
D126608
D126608_ALDRICH
DB00818
DDS-04F
Diisopropylphenol
Dipravan
Diprivan
Diprivan (TN)
Diprivan Injectable emulsion
Disoprivan
Disoprofol
EINECS 218-206-6
EU-0100437
Fresenius brand OF propofol
Fresenius Brand of Propofol
Fresenius kabi brand OF propofol
Fresenius Kabi Brand of Propofol
Fresofol
ghl.PD_Mitscher_leg0.558
HMS1570L04
HMS2089O21
HMS2094E17
HSDB 7123
|
ICI 35,868
ICI 35868
ICI35,868
ICI-35,868
ICI35868
ICI-35868
InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H
Ivofol
Jsp004266
Juste brand OF propofol
Juste Brand of Propofol
Lopac0_000437
Lopac-D126608
LS-996
MLS001066348
MLS001335999
MLS002454360
MolPort-001-794-517
NCGC00015389-01
NCGC00015389-02
NCGC00015389-04
NCGC00015389-09
NCGC00091538-01
NCGC00091538-02
NCGC00091538-03
NCGC00091538-04
NCGC00091538-05
NCGC00091538-06
nchembio.552-comp7
NSC 5105
NSC5105
Parnell brand OF propofol
Parnell Brand of Propofol
PFL
Pisa brand OF propofol
Pisa Brand of Propofol
Prestwick0_000931
Prestwick1_000931
Prestwick2_000931
Prestwick3_000931
propofol
Propofol
Propofol (JAN/USAN/INN)
Propofol [USAN:INN:BAN]
Propofol abbott
Propofol Abbott
Propofol fresenius
Propofol Fresenius
Propofol IDD-D
Propofol MCT
Propofol rovi
Propofol Rovi
Propofol(2,6-Diisopropylphenol)
Propofol-lipuro
Propofol-Lipuro
Propofolum
Propofolum [Latin]
Rapinovet
Recofol
Rovi brand OF propofol
Rovi Brand of Propofol
S01-0189
SAM002264610
Schering brand OF propofol
Schering Brand of Propofol
SMR000059151
SPBio_003031
SPECTRUM1505022
ST50405911
UNII-YI7VU623SF
W505102_ALDRICH
ZD-0859
Zeneca brand OF propofol
Zeneca Brand of Propofol
ZINC00968303
|
|
8 |
|
Desflurane |
Approved |
Phase 4 |
|
57041-67-5 |
42113 |
Synonyms:
(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
(±)-2-difluoromethyl 1,2,2,2-tetrafluoroethyl ether
1,1,1,2-tetrafluoro-2-(difluoromethoxy)ethane
1,1,1,2-tetrafluoro-2-(Difluoromethoxy)ethane
2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane
57041-67-5
AC1L274J
AC1Q4ICY
Baxter anaesthesia brand OF desflurane
Baxter brand OF desflurane
C07519
C3H2F6O
CHEBI:4445
CHEMBL1200733
CID42113
D00546
DB01189
Desflurane
DESFLURANE
Desflurane (JAN/USP/INN)
|
Desflurane [USAN:INN]
Desflurano
Desflurano [INN-Spanish]
Desfluranum
Desfluranum [INN-Latin]
difluoromethyl 1,2,2,2-tetrafluoroethyl ether
Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
I 653
I653
I-653
LS-65505
MolPort-001-776-387
Ohmeda brand OF desflurane
PC6781E
r-e 236ea1
Suprane
Suprane (TN)
UNII-CRS35BZ94Q
Zeneca brand OF desflurane
|
|
9 |
|
Neostigmine |
Approved, Vet_approved |
Phase 4 |
|
59-99-4 |
4456 |
Synonyms:
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate (ester)
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamic acid
[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium
[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium
[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide
114-80-7 (bromide)
3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium
3-{[(dimethylamino)carbonyl]oxy}-N,N,N-trimethylanilinium
3-Trimethylammoniumphenyl N,N-dimethylcarbamate
3-Trimethylammoniumphenyl N,N-dimethylcarbamic acid
51-60-5 (methyl sulfate)
59-99-4
AB00053807
AC1L1I7G
Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester)
Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl- (9CI)
bmse000762
BPBio1_000634
BRD-K18922609-004-04-1
BRN 3615946
Bromide, neostigmine
BSPBio_000576
C07258
CAS-114-80-7
CCRIS 3079
CHEBI:7514
CID4456
D08261
DB01400
DivK1c_000165
DivK1c_000198
Eustigmin
Eustigmine
HMS2089A22
HSDB 3921
IDI1_000165
IDI1_000198
InChI=1/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1
Intrastigmina
Juvastigmin
KBio1_000165
KBio1_000198
KBio2_001541
KBio2_004109
KBio2_006677
KBioGR_000623
KBioSS_001541
Lopac0_000816
|
Lopac-N-2001
LS-18452
Methylsulfate, neostigmine
m-Trimethylammoniumphenyldimethylcarbamate
m-Trimethylammoniumphenyldimethylcarbamic acid
NCGC00015730-01
NCGC00015730-02
NCGC00015730-03
NCGC00015730-04
NCGC00015730-08
NCGC00021658-03
NCGC00163240-01
nchembio.188-comp33
Neostigmin
Neostigmina
NEOSTIGMINE
Neostigmine (BAN)
Neostigmine [BAN]
Neostigmine bromide
Neostigmine methylsulfate
Neostigmine omega
Neostigminum
NINDS_000165
NINDS_000198
Polstigmine
Prestwick0_000468
Prestwick1_000468
Prestwick2_000468
Prestwick3_000468
Proserine
Prostigmin
Prostigmin (TN)
Prostigmine
Prozerin
SPBio_001276
SPBio_002515
Spectrum_001061
Spectrum2_001278
Spectrum4_000072
Spectrum5_001234
STL058953
sulfonatooxymethane
Synstigmin
Syntostigmine
UNII-3982TWQ96G
Vagostigmin
Vagostigmine
ZINC00001792
|
|
10 |
|
Remifentanil |
Approved |
Phase 4 |
|
132875-61-7 |
60815 |
Synonyms:
132539-07-2 (mono-hydrochloride)
132875-61-7
1-Piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester
3-(4-methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester
3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester
4-carboxy-4-(n-phenylpropionamido)-1-piperidinepropionic acid dimethyl ester
AC1L1TZ8
AC1Q5ZGR
BIDD:GT0029
C08021
CHEBI:8802
CHEMBL1005
CID60815
D08473
DB00899
DEA No. 9739
GI 87084B
|
GI 87084X
GI87084B
L001266
LS-115982
methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate
MolPort-004-286-006
Remifentanil
REMIFENTANIL
Remifentanil (INN)
Remifentanil [INN:BAN]
Remifentanil hydrochloride
Remifentanil monohydrochloride
Remifentanilo
Remifentanyl
Ultiva
Ultiva (TN)
UNII-P10582JYYK
|
|
11 |
|
Poractant alfa |
Approved |
Phase 4 |
|
129069-19-8 |
|
12 |
|
Lisinopril |
Approved, Investigational |
Phase 4 |
|
76547-98-3, 83915-83-7 |
5362119 |
Synonyms:
(2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
[N2-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline
[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE
1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline
76547-98-3
77726-95-5
83915-83-7 (Parent)
AC1NSFPF
Acerbon
Acercomp
Alapril
BB_NC-1454
BIDD:GT0755
BPBio1_000290
BRD-K67966701-335-03-5
BRN 4276619
BSPBio_000262
C21H31N3O5
Carace
CCRIS 3568
CHEBI:43755
CHEMBL1237
CID5362119
Cipral
Cipril
Coric
D08131
DB00722
DivK1c_001037
Doneka
EINECS 278-488-1
HMS1921B14
HMS2090O14
HMS2092L21
HMS503O15
I06-1895
ICI-209K
IDI1_001037
Inhibril
Inopril
KBio1_001037
KBio2_000977
KBio2_003545
KBio2_006113
KBio3_002002
KBioGR_001599
KBioSS_000977
L0220
Linopril
Linvas
Lipril
Lisinal
lisinopril
|
Lisinopril
Lisinopril (anhydrous)
Lisinopril (INN)
Lisinopril anhydrous
Lisinopril Dihydrate
Lisinopril maleate (1:1)
Lisinopril sulfate (1:2)
Lisinoprilum
Lisinoprilum [Latin]
Lisipril
Lisoril
Lispril
Longes
Loril
LPR
LS-118899
Lysinopril
MK 521
MK 522
MK-521
MLS001306436
MLS001306481
MolPort-002-507-428
N-(1(S)-Carboxy-3-phenylpropyl)-L-lysyl-L-proline
N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
N2-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl-L-proline
N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
NCGC00179623-01
NINDS_001037
Noperten
Novatec
Presiten
Prestwick0_000301
Prestwick1_000301
Prestwick2_000301
Prestwick3_000301
Prinil
Prinivil
Prinzide
Renacor
Sinopril
Sinopryl
SMR000544473
SPBio_001351
SPBio_002481
Spectrum_000497
SPECTRUM1501217
Spectrum2_001456
Spectrum3_000941
Spectrum4_001040
Spectrum5_000995
Tensopril
Tensyn
Tersif
TL8005499
Vivatec
Zestoretic
Zestril
Zestril (TN)
|
|
13 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-carboxy-3-hydroxypentane-1,5-dioic acid
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
|
Citretten
Citric acid monoglyceride
Citric acid monohydrate
Citric acid, anhydrous
Citric Acid, Anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
H3Cit
Hydrocerol a
Kyselina citronova
Monohydrate, citric acid
Suby g
Uralyt u
uro-Trainer
|
|
14 |
|
Ramosetron |
Investigational |
Phase 4 |
|
132036-88-5 |
|
Synonyms:
|
15 |
|
Gastrointestinal Agents |
|
Phase 4 |
|
|
|
16 |
|
Anti-Ulcer Agents |
|
Phase 4 |
|
|
|
17 |
|
Antacids |
|
Phase 4 |
|
|
|
18 |
|
Citrate |
|
Phase 4 |
|
|
|
19 |
|
Cathartics |
|
Phase 4 |
|
|
|
20 |
|
Chelating Agents |
|
Phase 4 |
|
|
|
21 |
|
Laxatives |
|
Phase 4 |
|
|
|
22 |
|
Anticoagulants |
|
Phase 4 |
|
|
|
23 |
|
Calcium, Dietary |
|
Phase 4 |
|
|
|
24 |
|
Picosulfate sodium |
|
Phase 4 |
|
|
|
25 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
26 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
27 |
|
Antibiotics, Antitubercular |
|
Phase 4 |
|
|
|
28 |
|
beta-Lactamase Inhibitors |
|
Phase 4 |
|
|
|
29 |
|
Hypnotics and Sedatives |
|
Phase 4 |
|
|
|
30 |
|
Anesthetics, General |
|
Phase 4 |
|
|
|
31 |
|
Anesthetics, Intravenous |
|
Phase 4 |
|
|
|
32 |
|
Cholinesterase Inhibitors |
|
Phase 4 |
|
|
|
33 |
|
Glycopyrrolate |
|
Phase 4 |
|
596-51-0 |
3494 |
Synonyms:
(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate
(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate bromide
.beta.-1-Methyl-3-pyrrolidyl-.alpha.-cyclopentylmandelate methobromide
1,1-Dimethyl-3-hydroxypyrrolidinium bromide .alpha.-cyclopentylmandelate
1,1-Dimethyl-3-hydroxypyrrolidinium bromide alpha-cyclopentylmandelate
1-Methyl-3-pyrrolidinyl .alpha.-phenylcyclopentaneglycolate methobromide
1-Methyl-3-pyrrolidyl alpha-phenylcyclopentaneglycolate methobromide
3-(erythro-2-Cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidiniumbromid
3-Hydroxy-1,1-dimethylpyrrolidinium bromide .alpha.-cyclopentylmandelate
3-Hydroxy-1,1-dimethylpyrrolidinium bromide alpha-cyclopentylmandelate
3-Hydroxy-1,1-dimethylpyrrolidinium bromide-.alpha.-cyclopentylmandelate
53808-86-9
596-51-0
AB00513912
AC-15990
AC1L1G28
AC1L1XX0
AC1LAW54
AC1Q1RGS
AC1Q60WT
AD-237
AHR 504
AHR-504
AR-1J1255
Asecryl
BPBio1_000806
Bromure de glycopyrronium
Bromure de glycopyrronium [INN-French]
Bromure de ritropirronio
Bromure de ritropirronium
Bromuro de glicopirronio
Bromuro de glicopirronio [INN-Spanish]
BSPBio_000732
C19H28NO3
CHEMBL1201027
CHEMBL1201335
CID11693
CID3494
CID521843
Copyrrolate
CPD000469282
Cuvposa
D00540
DB00986
EINECS 209-887-0
Gastrodyn
GLYCOPYRROLATE
Glycopyrrolate (USP)
Glycopyrrolate [USAN]
Glycopyrrolate bromide
Glycopyrroni bromidum
Glycopyrronii bromidum
Glycopyrronii bromidum [INN-Latin]
|
Glycopyrronium
glycopyrronium bromide
Glycopyrronium bromide
Glycopyrronium bromide (JAN/INN)
HMS1570E14
HMS2051P12
HMS2094A05
I14-3643
L001045
LS-138344
Mandelic acid, .alpha.-cyclopentyl-, ester with 3-hydroxy-1,1-dimethylpyrrolidinium bromide
MLS001424112
MLS002222301
MolPort-002-885-831
NCGC00179456-01
Nodapton
NSC 250836
NSC 251251
NSC 251252
NSC250836
NSC251251
NSC251252
NVA 237
NVA-237
Prestwick0_000746
Prestwick1_000746
Prestwick2_000746
Prestwick3_000746
PT-001
Pyrrolidinium, 1,1-dimethyl-3-hydroxy-, bromide, alpha-cyclopentylmandelate
Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide
Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-, bromide
Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, bromide, .alpha.-cyclopentylmandelate
Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, bromide, alpha-cyclopentylmandelate
Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, bromide, alpha-cyclopentylmandelate (8CI)
Ritropirronium bromide
Ritropirronium bromide [INN]
Robanul
Robinal
Robinul
Robinul (TN)
ROBINUL FORTE
Salt*)
SAM001246629
SAM002589987
SMR000469282
SPBio_002671
ST51054976
Tarodyl
Tarodyn
UNII-V92SO9WP2I
WLN: T5KTJ A1 A1 COVXQR&- AL5TJ &Q &E
|
|
34 |
|
Amoxicillin-Potassium Clavulanate Combination |
|
Phase 4 |
|
|
|
35 |
|
Analgesics |
|
Phase 4 |
|
|
|
36 |
|
Pulmonary Surfactants |
|
Phase 4 |
|
|
|
37 |
|
Narcotics |
|
Phase 4 |
|
|
|
38 |
|
Analgesics, Opioid |
|
Phase 4 |
|
|
|
39 |
|
Cardiotonic Agents |
|
Phase 4 |
|
|
|
40 |
|
Antihypertensive Agents |
|
Phase 4 |
|
|
|
41 |
|
Angiotensin-Converting Enzyme Inhibitors |
|
Phase 4 |
|
|
|
42 |
|
protease inhibitors |
|
Phase 4 |
|
|
|
Synonyms:
|
43 |
|
HIV Protease Inhibitors |
|
Phase 4 |
|
|
|
44 |
|
Protective Agents |
|
Phase 4 |
|
|
|
45 |
|
Calcium |
Nutraceutical |
Phase 4 |
|
7440-70-2 |
271 |
Synonyms:
Blood coagulation factor XIII
Ca
Ca(2+)
Ca2+
Calcio
Calcium
Calcium element
CALCIUM ion
Calcium, doubly charged positive ion
Calcium, elemental
Coagulation factor XIII
Elemental calcium
Factor XIII
|
Factor XIII a chain
Factor XIII a-chain
Factor XIII transamidase
Factor XIII, coagulation
Fibrin stabilizing factor
Fibrinase
Kalzium
Laki lorand factor
Laki-lorand factor
Stabilizing factor, fibrin
Transamidase, factor XIII
XIII, coagulation factor
|
|
46 |
|
Ampicillin |
Approved, Vet_approved |
Phase 3 |
|
69-53-4 |
6249 |
Synonyms:
(2S,5R,6R)-6-[[(2R)-2-amino-2-Phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylIC ACID
1h8s
33604-21-6
37234-64-3
47355-94-2
50584-05-9
6-(a-aminophenylacetamido)Penicillanic acid
6-(D(-)-alpha-aminophenylacetamido)Penicillanic acid
6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid
6-(D-(2-amino-2-phenylacetamido))-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
6-(D-(2-amino-2-phenylacetamido))-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
6-[(Aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9ci
69-52-3 (mono-hydrochloride salt)
69-53-4
6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
6-D(-)-alpha-aminophenylacetamido-Penicillanic acid
7177-48-2 (TRIHYDRATE)
800-79-3
8056-87-9
96707-69-6
98520-55-9
A9393_SIGMA
ABPC
AB-PC
AB-PC Sol
AC-14075
AC1L1M46
Acillin
Adobacillin
Alpen
alpha-Aminobenzylpenicillin
Amblosin
Amcill
Amfipen
Amfipen V
Aminobenzyl penicillin
Aminobenzylpenicillin
Amipenix S
AMP
Ampen
AMPI
Ampi-bol
Ampichel
Ampicil
Ampicilina
Ampicilina [INN-Spanish]
ampicillanyl
ampicillin
Ampicillin
Ampicillin (anhydrous)
AMPICILLIN (SEE ALSO AMPICILLIN TRIHYDRATE 7177-48-2)
Ampicillin (USP/INN)
Ampicillin [USAN:BAN:INN:JAN]
Ampicillin [USAN:INN:BAN:JAN]
Ampicillin A
Ampicillin acid
Ampicillin anhydrate
Ampicillin anhydrous
Ampicillin Anhydrous
Ampicillin base
Ampicillin Base
Ampicillin sodium
Ampicillin trihydrate
Ampicillin, anhydrous
Ampicillina
Ampicillina [DCIT]
Ampicilline
Ampicilline [INN-French]
Ampicillinum
Ampicillinum [INN-Latin]
Ampicin
Ampi-co
Ampi-Co
Ampifarm
Ampikel
Ampimed
Ampipenin
Ampipenin, nt3
Ampiscel
Ampisyn
Ampi-tab
Ampi-Tab
Ampivax
Ampivet
Amplacilina
Amplin
Amplipenyl
Amplisom
Amplital
Ampy-Penyl
anhydrous ampicillin
Anhydrous ampicillin
Anhydrous ampicillin (JP15)
Antibiotic KS R1
Antibiotic KS-R1
AP
Austrapen
AY 6108
AY 6108
AY-6108
BA 7305
Bayer 5427
BIDD:GT0184
Binotal
Bonapicillin
BPBio1_000142
Britacil
BRL 1341
BRL-1341
BSPBio_000128
BSPBio_001862
C06574
Campicillin
CHEBI:28971
CHEBI:53713
CHEMBL174
CID6249
Cimex
Copharcilin
D-(-)-6-(a-aminophenylacetamido)Penicillanate
D-(-)-6-(a-aminophenylacetamido)Penicillanic acid
D-(-)-6-(alpha-aminophenylacetamido)Penicillanate
D-(-)-6-(alpha-aminophenylacetamido)Penicillanic acid
D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid
D-(-)-6-(α-aminophenylacetamido)penicillanate
D-(-)-6-(α-aminophenylacetamido)penicillanic acid
D-(−)-6-(α-aminophenylacetamido)penicillanic acid
D-(-)-alpha-Aminobenzylpenicillin
D-(-)-alpha-Aminopenicillin
D-(−)-ampicillin
D-(-)-Ampicillin
D00204
D-a-Aminobenzylpenicillin
|
D-Ampicillin
DB00415
D-Cillin
Delcillin
Deripen
Divercillin
DivK1c_000466
Doktacillin
Duphacillin
EINECS 200-709-7
Geocillin
Grampenil
Guicitrina
Guicitrine
HI 63
HMS2090I11
HSDB 3009
IDI1_000466
KBio1_000466
KBio2_000430
KBio2_002998
KBio2_005566
KBio3_001362
KBioGR_000598
KBioSS_000430
KS-R1
KS-R1, Antibiotic
Lifeampil
LS-1586
LS-169948
Magnapen
Marcillin
MLS000028405
MLS001074168
MolPort-001-794-635
Morepen
NCGC00023282-05
NCGC00023282-06
NINDS_000466
Norobrittin
novo-Ampicillin
Novo-ampicillin
NSC 528986
NSC528986
NSC-528986
Nuvapen
Olin kid
Olin Kid
Omnipen
OMNIPEN (AMPICILLIN)
Omnipen (TN)
Omnipen-N
Orbicilina
P 50
P-50
Pen a
Pen A
Pen A Oral
Pen ampil
Pen Ampil
Penbristol
Penbritin
Penbritin paediatric
Penbritin syrup
Penbritin-S
Penbrock
Penicillin, aminobenzyl
Penicillin, Aminobenzyl
Penicline
Penimic
Pensyn
Pentrex
Pentrexl
Pentrexyl
Pentritin
Pfizerpen a
Pfizerpen A
Pfizerpen-A
Polycillin
Polycillin-N
Polyflex (Veterinary)
Ponecil
Prestwick0_000114
Prestwick1_000114
Prestwick2_000114
Prestwick3_000114
Princillin
Principen
Principen '125'
Principen '250'
Principen '500'
Qidamp
QIDamp
Racenacillin
ro-Ampen
Ro-Ampen
Rosampline
Roscillin
SBB063111
Semicillin
Semicillin R
Servicillin
SK-Ampicillin
SMP1_000211
SMR000058352
Sodium, ampicillin
SPBio_000818
SPBio_002067
Spectrum_000050
Spectrum2_000769
Spectrum3_000301
Spectrum4_000149
Spectrum5_000814
SQ 17382
Sumipanto
Supen
Synpenin
Texcillin
Tokiocillin
Tolomol
Totacillin
Totacillin (sodium)
Totacillin-N
Totalciclina
Totapen
Trifacilina
Trihydrate, ampicillin
Ukapen
Ultrabion
Ultrabron
UNII-7C782967RD
Vampen
Viccillin
Viccillin S
Vidocillin
Vidopen
WY-5103
Wypicil
|
|
47 |
|
Sulbactam |
Approved |
Phase 3 |
|
68373-14-8 |
|
Synonyms:
(2S,5R)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid 4,4-dioxide
(2S,5R)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
Penicillanic acid 1,1-dioxide
|
Penicillanic acid sulfone
Sulbactam
Sulbactamum
|
|
48 |
|
Estradiol |
Approved, Investigational, Vet_approved |
Phase 3 |
|
50-28-2 |
5757 |
Synonyms:
(+)-3,17b-Estradiol
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17beta)-Estra-1,3,5(10)-triene-3,17-diol
(17β)-estra-1,3,5(10)-triene-3,17-diol
.alpha.-Estradiol
.alpha.-Oestradiol
.beta.-Estradiol
.beta.-Oestradiol
[2,4,6,7-3H]-E2
[3H]]estradiol
[3H]-estradiol
13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol
17 beta Estradiol
17 beta Oestradiol
17 beta-Estradiol
17 beta-Oestradiol
17.beta.-Estradiol
17-.BETA.-Estradiol
17.beta.-Oestradiol
17b Oestradiol
17b-Estra-1,3,5(10)-triene-3,17-diol
17b-Estradiol
17-beta
17beta oestradiol
17beta Oestradiol
17beta-Estra-1,3,5(10)-triene-3,17-diol
17-beta-estradiol
17beta-Estradiol
17beta-Oestradiol
17-beta-OH-estradiol
17b-Oestradiol
17E
17-E
17β oestradiol
17β-estra-1,3,5(10)-triene-3,17-diol
17β-estradiol
17β-oestradiol
1jgl
1qkt
1qku
2d06
3,17.beta.-Estradiol
3,17b-Dihydroxyestra-1,3,5(10)-triene
3,17b-Estradiol
3,17beta-Estradiol
3,17-beta-Estradiol
3,17-beta-Oestradiol
3,17-Epidihydroxyestratriene
50-28-2
73459-61-7
873662-39-6
AC-10460
AC1L1L2K
Aerodiol
Agofollin
Alora
Altrad
Amnestrogen
Aquadiol
Bardiol
b-Estradiol
B-Estradiol
beta-Estradiol
Beta-estradiol
BIDD:ER0125
BIDD:PXR0065
Bio-0812
Bio1_000403
Bio1_000892
Bio1_001381
Bio2_000363
Bio2_000843
Bio-E-Gel
bmse000642
BPBio1_000532
BSPBio_000482
BSPBio_001065
C00951
C18H24O2
CCRIS 280
CHEBI:16469
CHEMBL135
CID5757
cis-Estradiol
cis-Oestradiol
Climaderm
Climara
Climara (TN)
Climara Forte
cMAP_000005
CMC_11154
component of Menrium
Compudose
Compudose 200
Compudose 365
Corpagen
CPD000059126
CPD-352
D00105
D-3,17beta-Estradiol
DB00783
delta-Estradiol
delta-Oestradiol
Dermestril
Destradiol
D-Estradiol
Dihydrofollicular hormone
Dihydrofolliculin
Dihydromenformon
dihydro-Theelin
Dihydrotheelin
Dihydroxyesterin
Dihydroxyestrin
Dihydroxyoestrin
Dimenformon
Diogyn
Diogynets
Divigel
Divigel (TN)
D-Oestradiol
E 2
E 8875
E(sub 2)
E0025
E1024_SIGMA
E1132_SIGMA
E2257_SIGMA
E2758_SIGMA
E8875_SIGMA
EINECS 200-023-8
Elestrin
Encore
Epiestriol 50
Esclim
Estra-1,3,5(10)-triene-3,17b-diol
Estrace
Estrace (TN)
Estraderm
Estraderm (TN)
Estraderm MX
Estraderm TTS
Estraderm TTS 100
Estraderm TTS 50
estradiol
Estradiol
Estradiol [USAN:INN]
Estradiol 17 alpha
Estradiol 17 beta
Estradiol 17beta
Estradiol anhydrous
Estradiol hemihydrate
Estradiol hemihydrate, (17 alpha)-isomer
Estradiol monohydrate
Estradiol orion brand
Estradiol, (-)-isomer
Estradiol, (+-)-isomer
Estradiol, (16 alpha,17 alpha)-isomer
Estradiol, (16 alpha,17 beta)-isomer
Estradiol, (17-alpha)-isomer
Estradiol, (8 alpha,17 beta)-(+-)-isomer
Estradiol, (8 alpha,17 beta)-isomer
Estradiol, (9 beta,17 alpha)-isomer
Estradiol, (9 beta,17 beta)-isomer
Estradiol, monosodium salt
Estradiol, sodium salt
Estradiol-17 alpha
Estradiol-17 beta
Estradiol-17.beta.
Estradiol-17b
|
estradiol-17beta
Estradiol-17beta
Estradiol-17-beta
Estradiol-17β
Estradiol-3,17beta
Estradiolo
Estradiolo [DCIT]
Estradiolum
Estradiolum [INN]
Estradot
Estraldine
Estrapak 50
Estrasorb
Estrasorb (TN)
Estreva
Estrifam
Estring
Estring (TN)
Estring vaginal ring
Estroclim
Estroclim 50
Estrodiolum
Estrofem 2
Estrofem Forte
Estrogel
Estrogel (TN)
Estrogel HBF
Estrovite
EU-0100503
Evamist
Evorel
Extrasorb
Femanest
Femestral
Femestrol
Femogen
Fempatch
Femtrace
Femtran
Follicyclin
Gelestra
Ginedisc
Ginosedol
Gynergon
Gynestrel
Gynodiol
Gynoestryl
GynPolar
HMS1362E07
HMS1569I04
HMS1792E07
HMS1990E07
HMS2051C17
HMS2090E18
HSDB 3589
IDI1_002118
Innofem
Innofem (TN)
KBio2_000405
KBio2_002269
KBio2_002973
KBio2_004837
KBio2_005541
KBio2_007405
KBio3_000769
KBio3_000770
KBio3_002749
KBioGR_000405
KBioGR_002269
KBioSS_000405
KBioSS_002270
Lamdiol
LMST02010001
Lopac0_000503
LS-137
Macrodiol
Macrol
Menest
Menorest
Microdiol
MLS000069494
MLS000758312
MLS001076331
MolPort-001-794-632
NCGC00091544-00
NCGC00091544-01
NCGC00091544-02
NCGC00091544-04
NCGC00091544-05
NCGC00091544-06
NCGC00091544-07
NCGC00091544-08
NCGC00091544-09
NCGC00091544-12
NCGC00179321-01
NCGC00179321-02
nchembio.168-comp3
nchembio.76-comp2
nchembio775-comp2
nchembio794-comp6
nchembio860-comp1
Nordicol
Novartis pharmaceuticals brand OF estradiol
NSC9895
NSC-9895
Oesclim
Oestergon
Oestra-1,3,5(10)-triene-3,17b-diol
Oestradiol
Oestradiol Berco
Oestradiol R
Oestradiol-17.beta.
Oestradiol-17beta
Oestradiol-17-beta
Oestradiolum
Oestrogel
Oestroglandol
Oestrogynal
Orion brand OF estradiol
Ovahormon
Ovasterol
Ovastevol
Ovociclina
Ovocyclin
Ovocycline
Ovocylin
Perlatanol
Polyestradiol
Prestwick_207
Prestwick0_000441
Prestwick1_000441
Prestwick2_000441
Prestwick3_000441
Primofol
Profoliol
Profoliol b
Profoliol B
progynon
Progynon
Progynon DH
Progynon-DH
S1709_Selleck
S-21400
SAM001247032
Sandrena 1
Sandrena Gel
Sisare Gel
SK-Estrogens
SL-1100
SMP1_000121
SMR000059126
SPBio_002421
Spectrum5_002055
Syndiol
Systen
Tradelia
Trial SAT
Trocosone
UNII-4TI98Z838E
Vagifem
Vagifem (TN)
Vivelle
Vivelle (TN)
VIVELLE-DOT
Zerella
Zesteem
Zesteen
Zumenon
β-estradiol
|
|
49 |
|
Norgestimate |
Approved, Investigational |
Phase 3 |
|
35189-28-7 |
6540478 |
Synonyms:
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetic acid (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one oxime acetate (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one oxime acetic acid (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one oxime acetate (ester)
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one oxime acetic acid (ester)
(17a)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(17α)-17-(acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(17α)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(3E)-17alpha-ethynyl-3-(hydroxyimino)-18a-homoestr-4-en-17beta-yl acetate
[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
35189-28-7
AC1O712U
AC-655
C017576
CHEBI:50815
CHEMBL1200934
CID6540478
D 138
D05209
d-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime
d-13-beta-Ethyl-17-alpha-ethynyl-17-beta-acetoxygon-4-en-3-one oxime
D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime
D-13b-Ethyl-17a-ethynyl-17b-acetoxygon-4-en-3-one oxime
|
D-13β-ethyl-17α-ethynyl-17β-acetoxygon-4-en-3-one oxime
d-13β-Ethyl-17α-ethynyl-17β-acetoxygon-4-en-3-one oxime
DB00957
Dexnorgestrel acetime
Dexnorgestrel Acetime
I14-9729
LS-62080
NCGC00181353-01
Norgestimate
NORGESTIMATE
Norgestimate (USP/INN)
Norgestimate [USAN:INN:BAN]
Norgestimato
Norgestimato [INN-Spanish]
Norgestimatum
Norgestimatum [INN-Latin]
Norgestimic acid
norgestrel oxime acetate
Norgestrel oxime acetate
ORF 10131
ORF-10131
Ortho-Prefest
RWJ 10131
RWJ-10131
UNII-C291HFX4DY
ZINC03938695
|
|
50 |
|
Moxifloxacin |
Approved, Investigational |
Phase 3 |
|
354812-41-2, 151096-09-2 |
152946 |
Synonyms:
(1'S,6'S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
151096-09-2
186826-86-8
192927-63-2
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylate
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid
AC1L49EP
Actira
Actira (*Hydrochloride*)
Avalox
Avelox
Avelox (*Hydrochloride*)
Avelox I.V.
BAY 12-8039
BAY 12-8039 (*Hydrochloride*)
CCRIS 8690
|
CHEMBL32
CID152946
DB00218
I06-1961
Izilox
LS-141510
MFX
moxifloxacin
Moxifloxacin
Moxifloxacin [INN:BAN]
Moxifloxacin HCl
Moxifloxacin hydrochloride
Moxifloxacino
MXF
MXFX
Octegra
Proflox
UNII-U188XYD42P
Vigamox
|
|
Interventional clinical trials:
(show top 50)
(show all 166)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Phase IV, Prospective, Randomized Study Comparing Preparation the Day Before and Split-dose Regimen With Sodium Picosulphate/Magnesium Citrate for Morning Colonoscopies |
Unknown status |
NCT01481714 |
Phase 4 |
Sodium picosulphate, magnesium oxid and citric acid;Sodium picosulphate/magnesium oxide and citric acid |
2 |
Laryngoscope Versus CMAC for Endotracheal Intubation in Patients Undergoing Emergent Airway Management |
Completed |
NCT01710891 |
Phase 4 |
|
3 |
The Effect of Total Intravenous Anesthesia With Propofol on Postoperative Nausea and Vomiting in Patients Undergoing Robot-assisted Laparoscopic Radical Prostatectomy |
Completed |
NCT01402622 |
Phase 4 |
Propofol anesthesia |
4 |
PROcalcitonin Pneumonia / Pneumonitis Associated With ASPIration |
Completed |
NCT02862314 |
Phase 4 |
|
5 |
The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications in Patients 70 Years or Older and Scheduled for 3 Hour or Longer Surgery-A Randomized Controlled Trial |
Completed |
NCT02861131 |
Phase 4 |
Sugammadex;Neostigmine |
6 |
Pneumonia in Children: Aetiology, Ideal Antibiotic Duration, Quality of Life |
Completed |
NCT02258763 |
Phase 4 |
Amoxicillin-Potassium Clavulanate Combination;Placebo |
7 |
Stress Assessment in Preterm Infants With Respiratory Distress Syndrome Treated or Not With an Analgesic Drug During the Traditional or the Less Invasive Method of Surfactant Therapy. |
Not yet recruiting |
NCT04073173 |
Phase 4 |
Analgesic, Opioid |
8 |
A Randomized Placebo Controlled Trial of Low Dose Angiotensin Converting Enzyme Inhibitor to Prevent Pneumonia in Older People Who Require Tube Feeding Because of Neurological Dysphagia |
Terminated |
NCT02358642 |
Phase 4 |
Angiotensin converting enzyme inhibitor (Lisinopril);Placebo |
9 |
Surfactant Lavage vs. Bolus Surfactant in Neonates With Meconium Aspiration |
Unknown status |
NCT00312507 |
Phase 3 |
Bovine Lipid Extract Surfactant (administered by lavage);Bovine Lipid Extract Surfactant (administered by bolus) |
10 |
Efficacy and Cost Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Locally Advanced Head and Neck Cancer to Prevent Aspiration Pneumonia. A Randomized Phase II-III Study |
Unknown status |
NCT01598402 |
Phase 2, Phase 3 |
amoxicillin/clavulanic acid suspension |
11 |
Phase 2/3 Application of Botulinum Neurotoxin Type A in Salivary Glands as a Treatment of Chronic Drooling in Patients With Cerebral Palsy: A Controlled Clinical Trial. |
Unknown status |
NCT01489904 |
Phase 2, Phase 3 |
|
12 |
Prospective, Multi-center, Randomized, Non-blind Trial to Assess the Efficacy and Safety of Moxifloxacin Versus Sulbactam/Ampicillin in the Treatment of Pulmonary Abscess and Aspiration Pneumonia |
Completed |
NCT01045902 |
Phase 3 |
Avelox (Moxifloxacin, BAY12-8039);Sulbactam/Ampicillin |
13 |
A Randomised Controlled Trial of Dysphagia Therapies for Swallowing Disorders Following Stroke. |
Completed |
NCT00257764 |
Phase 2, Phase 3 |
|
14 |
Sellick Maneuver Evaluation in Rapid Sequence Induction of General Anesthesia Non Inferiority Trial |
Completed |
NCT02080754 |
Phase 3 |
|
15 |
The Effects of Bronchodilator Therapy On Respiratory and Autonomic Function in Patients With Familial Dysautonomia |
Completed |
NCT01987219 |
Phase 3 |
Albuterol-sulphate;Ipratropium-bromide |
16 |
Muscle Preservation and Swallow Function Following Radiotherapy: A Dose Response Study |
Completed |
NCT01279837 |
Phase 2, Phase 3 |
|
17 |
Esophageal Stent is More Effective Than Tamponade Controlling Refractory Esophageal Variceal Bleeding: a Randomized Controlled Trial |
Completed |
NCT01242280 |
Phase 3 |
|
18 |
Survey of Miglustat Therapeutic Effects on Neurological and Systemic Symptoms of Infantile Type of Sandhoff and Taysachs Diseases |
Recruiting |
NCT03822013 |
Phase 3 |
Miglustat |
19 |
Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia |
Terminated |
NCT01971320 |
Phase 3 |
|
20 |
Randomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term Effects |
Terminated |
NCT00000362 |
Phase 3 |
|
21 |
Regular Versus Liquid Diet as the First Meal in Patients Undergoing Major Abdominal Gynecologic Cancer Operation: A Randomized Controlled Trial |
Withdrawn |
NCT00328757 |
Phase 3 |
|
22 |
Effect of Daikenchuto (TJ-100) on Intestinal Dysmotility and For the Prevention of Postoperative Paralytic Ileus in Patients Undergoing Pancreaticoduodenectomy: A Multicenter, Randomized, Placebo-Controlled Phase II Trial |
Unknown status |
NCT01607307 |
Phase 2 |
Oral/enteral TJ-100 solution;Oral/enteral placebo solution |
23 |
Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI) |
Unknown status |
NCT02819479 |
Phase 2 |
25% Mannitol;Low-dose Intra-arterial Bevacizumab |
24 |
Effect of Oral Menthol on the Swallow Response of Patients With Oropharyngeal Dysphagia Associated With Neurological Diseases and Aging |
Completed |
NCT03050957 |
Phase 2 |
|
25 |
A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients |
Completed |
NCT00568698 |
Phase 1, Phase 2 |
Hydroxyurea;Placebo to match hydroxyurea |
26 |
Effectiveness of a New Neuromuscular Electrical Stimulation (NMES) Treatment Technique (VitalStim® Therapy) in the Management of Young Infants With Severe Dysphagia: a Prospective Pilot Study |
Completed |
NCT01723358 |
Phase 2 |
|
27 |
Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia |
Completed |
NCT01085903 |
Phase 2 |
Modafinil;Placebo |
28 |
Effect of Afferent Oropharyngeal Pharmacological and Electrical Stimulation on Swallow Response and on Activation of Human Cortex in Stroke Patients With Oropharyngeal Dysphagia (OD). A Randomized Controlled Trial. |
Completed |
NCT01777672 |
Phase 2 |
|
29 |
Establishing Normal Swallowing and Breathing Profiles in Healthy Adults Across the Age Span |
Completed |
NCT03122145 |
Phase 1, Phase 2 |
Capsaicin |
30 |
Aromatherapy for Postoperative Nausea and Vomiting in Children: A Single Blind Randomized Clinical Trial |
Completed |
NCT02663154 |
Phase 2 |
Aromatherapy inhaler;Saline inhaler |
31 |
Induction of Volitional Swallowing in Chronic Dysphagia Post Stroke: A Novel Mechanism-Based Intervention |
Completed |
NCT00306501 |
Phase 2 |
|
32 |
Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts |
Completed |
NCT00773227 |
Phase 2 |
|
33 |
Cough and Swallow Rehabilitation Following Stroke |
Completed |
NCT01907321 |
Phase 1, Phase 2 |
Measures performed on all subjects |
34 |
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial |
Recruiting |
NCT02927691 |
Phase 2 |
|
35 |
The Nutritional Supplement Phosphatidylserine in Patients With Familial |
Recruiting |
NCT02276716 |
Phase 2 |
Phosphatidylserine |
36 |
Therapeutic Impact of tDCS on Dysphagia in the Acute Phase of Stroke / Impact thérapeutique de la tDCS Sur la Dysphagie en Phase Aigue de l'Accident Vasculaire cérébral |
Active, not recruiting |
NCT01758991 |
Phase 1, Phase 2 |
|
37 |
Effect Of Early Initiation Of Noninvasive Positive Pressure Ventilation On ICU Length Of Stay In Children With Status Asthmaticus, A Prospective Randomized Trial |
Withdrawn |
NCT01403428 |
Phase 2 |
|
38 |
A Randomised Placebo Controlled Trial to Explore the Effectiveness of Botulinum Toxin Injection at Reducing Oral Secretions and Frequency of Tracheal Suctioning in Tracheotomised Patients. |
Withdrawn |
NCT00973999 |
Phase 2 |
Botulinum Toxin |
39 |
Comparison of GERD and the Effects of Anti-Reflux Therapy on Pulmonary Function Between Able-Bodied and SCI Individuals |
Unknown status |
NCT02584751 |
Phase 1 |
Omeprazole |
40 |
Airway Protection Deficits According to Stimulus Type in Parkinson's Disease |
Completed |
NCT02390089 |
Phase 1 |
Capsaicin vapor |
41 |
PentoxIfylline and Tocopherol for the Treatment of Post-radiotherapy Fibrosis in Head and Neck Cancer Patients: a Feasibility Study |
Not yet recruiting |
NCT03723291 |
Phase 1 |
|
42 |
Dynamic Laryngotracheal Separation for Aspiration. Prevention of Silent Aspiration Pneumonia During Swallowing by an Implanted Stimulator |
Suspended |
NCT00580346 |
Phase 1 |
|
43 |
Salivary Alpha Amylase Bronchial Measure for Early Aspiration Pneumonia Diagnosis in Patients Treated With Therapeutic Hypothermia After Out-of-hospital Cardiac Arrest. |
Unknown status |
NCT03007862 |
|
|
44 |
Continuous EtCO2 Monitoring in Acute Self Poisoned Patients Admitted in an Emergency Department |
Unknown status |
NCT01800123 |
|
|
45 |
Comparative Study of the Effect of Three Different Analgesic Techniques on the Incidence of Postoperative Nausea and Vomiting After Scleral Buckling Under General Anesthesia |
Unknown status |
NCT03313479 |
|
Dexmedetomidine |
46 |
Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation |
Unknown status |
NCT03108430 |
|
|
47 |
Establish Comprehensive Quantitative Measurements of Laryngeal Sensorimotor Functions and Evaluating the Grade of Phonation and Swallowing Impairment |
Unknown status |
NCT02243722 |
|
|
48 |
A Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation and Chemotherapy |
Unknown status |
NCT00536952 |
Early Phase 1 |
Pulmozyme;Placebo |
49 |
Incidence of Dysphagia in Intensive Care Patients With Tracheostomy Using High Resolution Pharyngoesophageal Manometry and Impedance |
Unknown status |
NCT02874352 |
|
|
50 |
Ultrasound Assessment of Gastric Content and Gastric Volume Before Crash Induction for Appendectomy |
Unknown status |
NCT02983175 |
|
|
|